Ingelheim International Gmbh Boehringer - Jun 27, 2023 Form 3 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
10%+ Owner
Signature
/s/ Christoph Gauger, Registered Manager (Prokurist), the GP, /s/ Martin Bergmann, Registered Manager (Prokurist), the GP
Stock symbol
NERV
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
3
Date filed
7/7/2023, 04:15 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NERV Common Stock 1.28M Jun 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NERV Pre-Funded Warrant (right to buy) Jun 27, 2023 Common Stock 225K $0.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held directly by Boehringer Ingelheim International GmbH ("International GmbH"), a wholly owned indirect subsidiary of C. H. Boehringer Sohn AG & Co. KG ("Parent"). Boehringer AG (the "GP") is the General Partner of Parent. Under Securities and Exchange Commission rules and regulations, the GP may be deemed to have indirect beneficial ownership of the shares held by International GmbH.
F2 The Pre-Funded Warrant will not expire until exercised in full.